Patients taking a compounded alternative to Eli Lilly's weight loss drug Zepbound are expected to transition to the ...

The U.S. Food and Drug Administration (FDA) announced on Monday the approval of the first generic version of a ...

The first medication for obstructive sleep apnea has been approved by the US Food and Drug Administration (FDA).

The US Food and Drug Administration has approved Zepbound (tirzepatide) as the first prescription medication for the treatment of obstructive sleep apnea (OSA).

The FDA first approved Zepbound to treat obesity in November 2023. Its active ingredient, tirzepatide, was previously ...

Novo Nordisk NVO announced disappointing data from a phase III study on a novel obesity candidate. The FDA approved Eli Lilly ...

In a new study, researchers examined the health effects people experienced when they returned to still-standing homes after ...

The recall, according to a news release published Wednesday, involves Northwest Naturals' Feline Turkey Recipe raw frozen pet ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 501.82% and ...

CEO's use of Eli Lilly's (LLY) weight loss drug Mounjaro over Novo Nordisk's (NVO) rival product, Ozempic. Read more here.

Dog the Bounty Hunter's daughter shared Nov. 1 that she had lost 58 pounds in 10 months thanks to a change in diet and the use of the weight loss medication Tirzepatide ... News that the drug is not ...